Post on 20-May-2020
©2018 WellDoc, Inc. Intellectual Property. All rights reserved
The Power and Promise of Digital Health
Laurel Pickering, MPHEVP, Enterprise SolutionsWelldoc, Inc.
Agenda• Problem are we trying to solve• Changing consumer and healthcare system• Digital health and digital therapeutics• Artificial intelligence • Diabetes and BlueStar as an example
What problem are we trying to solve?
Problems• Increasing health care costs• Increase in prevalence of chronic conditions (New CDC
numbers: 14% of Americans have diabetes)• Hard to get employees to take care of themselves and
engage in their health• Tried multiple programs; many don’t work
and employees don’t engage
Your employees are changing and so is healthcare
• The New Consumer
• Care is moving to virtual and on-demand
99
Meet LaraToday’s Healthcare Consumer
Music
MUSIC SPOTIFY
Music
COMMUTE UBER
Music
EXERCISE PELOTON
Music
DOCTOR TELEDOC
Characteristics of Lara’s Tools
©2018 WellDoc, Inc. Intellectual Property. All rights reserved
Personalized
©2018 WellDoc, Inc. Intellectual Property. All rights reserved
On-Demand
©2018 WellDoc, Inc. Intellectual Property. All rights reserved
Virtual
©2018 WellDoc, Inc. Intellectual Property. All rights reserved
24/7
1919
How do your tools fit into Lara’s expectations?
2020Diabetes Space
Confusion
314 Wearables available worldwide
60% of apps are just general wellness
Patie
nt C
hurn200 new apps each day
20% of large health systems have full-scale digital health programs
Digital Health Space
2121
Investor Trends: 2018 biggest year• Digital health is key focus of investors time and
money
• Healthcare at home/on-demand health tools
• Significant digital therapeutics fundraising:
• Pear Therapeutics ($46M)
• Click Therapeutics ($17M)
• Akili Interactive Labs ($68M)
• Virta Health ($45M)
• Propeller Health ($20M)
• Hinge Health ($26M)
• Focus on companies making care continuous, accessible, convenient
• 31 FDA approvals in digital health
• Big tech pushes into healthcare
• Amazon acquires PillPack
• Apple Watch Series 4
SVB Analytics, “Consumer Digital Health: How Market Shift is Leading to New Opportunities”, 2016
Software as Medicine: Digital Therapeutics
1. Data analysis and feedback is evidence and theory based and tailored to the individuals clinical needs, goals, and lifestyle
2. Connects the patient with their own health care team (integrate into practice)
3. Has demonstrated safety and efficacy in randomized clinical trials
4. Ensures the safety and security of the patient-generated health data
5. Obtained regulatory clearance when used as medical device and are developed in accordance with appropriate QA/RA standards
6. Designed to be user friendly and engaging
Digital therapeutics are at the forefront of a new era in digital health.
These clinically validated solutions may be used as standalone interventions or in association with other treatments to engage patients and improve the overall quality, cohesion, outcomes and value of healthcare delivery.
Criteria:
Where Does AI Fit In?
It’s a new world, where artificial intelligence (AI) is moving beyond a back-end tool for the healthcare enterprise to the forefront of the consumer and clinician experience.
AI is the New UI: Healthcare Experience Above All, Accenture, 2017
3434Spotlight on Diabetes
N O I S E I N T H E S Y S T E M
K E Y P L A Y E R S
People with Type 2 Diabetes Need a 24/7 Personal Assistant
*Turning the tide on diabetes management: How leaders in health care are using multi-faceted approaches, Deloitte, 2016
*
…and people need a digital assistant they can trust
“Yet this miracle of modern science is not a new pill. It is a smartphone app called BlueStar.”
”The BlueStar app…is one of only a few apps backed by data from clinical trials.”
“Adults with diabetes can use sophisticated mobile technology, such as Welldoc to effectively manage their lifestyles and conditions, reducing the need for in-person encounters.”
April 2018 January 2018April 2015
BlueStar Powered by WellDoc
• 1st digital therapeutic for diabetes
• 30 peer reviewed publications/posters including clinical outcomes in randomized controlled studies and real-world.
• Experience with 30,000 people with diabetes
• FDA Registered as a Class 2 Medical Device, works online & offline.
• HIPAA compliant. SOC 2 Certified. ISO 13485 for International Business
Our Solution
Digital Personal Assistant
Data-driven user experience and artificial intelligence combined with evidence-based medicine
Named
“Top App” for type 2diabetes treatment
by IQVIA November 2017
Source: IQVIA 2017 Report “The Growing Value of Digital Health”
BlueStar Ecosystem
Tailored, Comprehensive Experience
Symptoms(Surveys, Notes)
Psycho-social(Distress, Disability,
Economic Conditions)
Labs(BG, BP, Weight)
Activity(Sleep/Exercise)
Meds(Adherence, Insights)
Diet(Carbs, Calories, Sodium,
Water)
Unique, real-time feedback messages given within each dimension
Tracks and analyzes the 6 critical dimensions impacting diabetes, inclhypertension & weight management
Provider Smart Visit Report
Weekly Insights Longitudinal Patterns
Medication Reminders
Real-time Feedback
Plan & Track
A Closer Look at BlueStar
Connect
Key BlueStar Stats
24 weekly in-app actions
Engagement
Average Savings of $251-$274 per month
Time to ResultsMost A1C reductions seen in first 3 months
Clinical Results
1.7-2.0 Reduction in A1C
Cost Savings
Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011 Sep;34(9):1934-42. Erratum in: Diabetes Care. 2013 Nov;36(11):3850.Tang, P. Peeples, M. Duni, J. Peskin,S. Macleod, J. Kowitt, S. Fisher, E. eHealth-Assisted Lay Health Coaching for Diabetes Self-Management Support. ADA, New Orleans, 2016. Poster
1.9 Point A1C Improvement (mean)12 month RCT
2.0 Point A1C Improvement (mean)3 month RCT
58% Reduction in Hospitalizations & ER Visits
Peer-Reviewed Journals
OutcomesOver 32 peer reviewed posters and
presentations
Comparison of A1C ReductionT2D Treatment Average A1C Reduction
Insulin 1.5 - 2.5
BlueStar 1.7 - 2.0
Metformin 1.5
Sulfonylureas 1.5
SGLT-2s .5 - 1.0
GLP-1R Agonist .5 - 1.0
DPP-4 Inhibitor .6 - .8
BlueStar is second only to insulin in terms of ability to reduce A1C
No side effects
Fully scalable
Financial Outcomes
WellDoc Validates Potential of Its Digital
Therapeutic, BlueStar®, to Significantly Reduce
Healthcare Costs.
Cost savings based on:
• Reductions in hospitalizations• Emergency room visits• Supplies and medications• Co-morbid conditions
3-5xAverage ROI
$254-$271 Average Savings
per User per
Month
How Does it Work?• You purchase BlueStar for your employees/patients/members• We provide you with a unique code• We work with you to market the tool and target, if possible
• Email blast, posters, phone outreach, onsite enrollment, website, existing platform, clinician education, workflow
• Employees/members/patients download the app from app store• They use your unique code to activate • You provide eligibility file• We provide you with regular reporting: how many are using BlueStar, how often, what
features are they using, blood glucose values, medication adherence, preventive exams, etc.
Keeping BlueStar Users Engaged
“In-App” Engagement
“Out-of-App” Engagement
Dynamic Emails
Mobile Notifications
Targeted Re-Engagement Emails
BlueStar Team/Care Team Phone Outreach
Real-Time Feedback Messages
Longitudinal Feedback Messages
Weekly Challenges
Weekly Summaries
Diabetes Curriculum
In-app and out-of-app engagement methods
Helping people live their best life
“I can’t live without BlueStar!”
• 5.8 A1C reduction in about 7 months
• Lost weight (over 70 pounds)
• More active and living a healthy lifestyle
• Feels BlueStar helped her get her life back
• BlueStar helps her keep her diabetes in control
5.8 A1C reduction in ~7 monthsRecent A1C of 5.7 was recorded early Nov. 2017
Candy K. Barnes62 year old - ManagerMarch 2017 - Diagnosed with T2DApril 2017- Began BlueStar
Starting A1C: 11.5 Ending A1C: 5.7
11.5 5.7
It is amazing what a digital personal assistant can do for population health.